- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 7055
10-year publication summary
|
162
|
169
|
347
|
399
|
456
|
554
|
582
|
651
|
503
|
402
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9339 |
68 |
| Takeda Pharmaceutical Company Limited | 2706 |
52 |
| Novartis AG | 10709 |
43 |
| The Regents of the University of California | 20137 |
38 |
| Nestec S.A. | 2647 |
37 |
| DSM IP Assets B.V. | 5575 |
37 |
| Cedars-Sinai Medical Center | 1166 |
35 |
| N.V. Nutricia | 1064 |
33 |
| Janssen Pharmaceutica N.V. | 3370 |
31 |
| F. Hoffmann-La Roche AG | 7947 |
30 |
| The Johns Hopkins University | 5723 |
30 |
| Glycom A/S | 251 |
30 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
28 |
| Raqualia Pharma Inc. | 122 |
27 |
| Osaka University | 3394 |
25 |
| Astellas Pharma Inc. | 1088 |
24 |
| Eli Lilly and Company | 3908 |
24 |
| AstraZeneca AB | 2877 |
23 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
23 |
| Boehringer Ingelheim International GmbH | 4648 |
22 |
| Other owners | 6395 |